H-Asp-Ala-OH

CAS: 13433-02-8

Ref. 3D-FA107993

Produktinformation

• Name: H-Asp-Ala-OH
• Synonyme: 442: PN: WO2005081628 SEQID: 444 claimed protein, 9: PN: US20190082912 SEQID: 9 claimed protein, 9: PN: WO2015155710 SEQID: 9 claimed protein, <span class="text-smallcaps">L</smallcap>-Alanine, <smallcap>L</span>-α-aspartyl-, <span class="text-smallcaps">L</smallcap>-Alanine, N-<smallcap>L</span>-α-aspartyl-, <span class="text-smallcaps">L</smallcap>-Aspartyl-<smallcap>L</span>-alanine, <span class="text-smallcaps">L</smallcap>-α-Aspartyl-<smallcap>L</span>-alanine, Alpha-Aspartylalanine, Aspartylalanine, L-alpha-aspartyl-L-alanine, Succinamic acid, 3-amino-N-(1-carboxyethyl)-, stereoisomer, α-<span class="text-smallcaps">L</smallcap>-Aspartyl-<smallcap>L</span>-alanine

Beschreibung

Adriamycin is an anticancer drug that is a structural analogue of aspartic acid. It can be synthesized in a solid-phase synthesis using a polymeric resin with an acidic functional group, such as H-Asp-Ala-OH. Adriamycin inhibits the production of inflammatory cytokines and prostaglandins, which are involved in the development of inflammatory diseases. Adriamycin has been shown to have anti-inflammatory effects on human serum and to inhibit the production of proteins important for tumor cell proliferation. Adriamycin also has anti-inflammatory properties due to its ability to bind with hydrogen bonds to acidic residues on proteins.
END>

• Marke: Biosynth

Chemische Eigenschaften

• Molekulargewicht: 204.18 g/mol
• Formel: C₇H₁₂N₂O₅
• Reinheit: Min. 98 Area-%
• Farbe/Form: Powder